Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 279 resources
-
Needle Exchange Surveillance Initiative: Prevalence of blood-borne viruses and injecting risk behaviours among people who inject drugs attending injecting equipment provision services in Scotland, 2008 to 2020
The Needle Exchange Surveillance Initiative (NESI) has published its latest report using survey data to measure and monitor the prevalence of blood-borne viruses – hepatitis C virus and HIV – and injecting risk behaviours among people who inject drugs (PWID) in Scotland.
The report uses data from Scotland level and NHS board level surveys, and provides information to evaluate and better target interventions aimed at reducing the spread of infection amongst PWID.
Some key findings of the report include:
Scotland Reports & Research PDF -
Reframing Reinfection: towards sustained hepatitis C elimination in the UK (2022)
A joint effort by HCV Action and The Hepatitis C Trust, this report sets out to understand what the NHS and frontline services who work with people at risk of hepatitis C are seeing in relation to reinfection, what is already being done, and what more we might put in place locally and nationally to address this.UK Reports & Research PDF -
Hepatitis C in England 2022: full report
The 2022 Hepatitis C in England report from the UK Health Security Agency reports that deaths from hepatitis C fell by 35% between 2015 and 2020. The data shows the estimated prevalence of chronic hepatitis C in England has continued to decline to around 81,000 in 2020 (compared to 129,000 in 2015) – a 37% fall in the general population. Provisional data suggests that there has been a 40% decline in people who inject drugs.England 03 Mar 2022 Reports & Research PDF -
Hepatitis C in England 2022: short report
This resource is a shorter version of the full Hepatitis C in England 2022 report from the UK Health Security Agency. The report details that deaths from hepatitis C fell by 35% between 2015 and 2020. The data shows the estimated prevalence of chronic hepatitis C in England has continued to decline to around 81,000 in 2020 (compared to 129,000 in 2015) – a 37% fall in the general population. Provisional data suggests that there has been a 40% decline in people who inject drugs.England 03 Mar 2022 Reports & Research PDF -
Hepatitis C in England 2022: Infographics
These infographics from the UK Health Security Agency provide a visual representation of the data from the Hepatitis C in England 2022 report.England 03 Mar 2022 Reports & Research PDF -
Webinar summary: Hepatitis C services in Wales, January 2022
The HCV Action webinar on Hepatitis C services in Wales took place in January 2022, and addressed the current status of hepatitis C services in Wales. Bringing together professionals from University Hospital Wales, Cardiff and Vale University Health Board, The Hepatitis C Trust and the Welsh Government, the webinar explored a range of issues in Wales’ journey to elimination. This resource offers an overview of all presentations .Wales 14 Feb 2022 Reports & Research, Strategy & Planning PDF -
Shooting Up: infections among people who inject drugs in the UK, 2020
Published by the UK Health Security Agency, this report describes the extent of infections and injecting-related harms among people who inject drugs (PWID), who experience substantially worse health outcomes than the general population.
UK 10 Feb 2022 Reports & Research PDF -
Webinar recording: Hepatitis C services in Wales
This webinar explores hepatitis C services in Wales, with talks on BBV services, peer-to-peer support, drug services, and treatment for children and young people. Including presentations from expert speakers from the University Hospital of Wales, Cardiff and Vale University Health Board, The Hepatitis C Trust, and the Welsh Government, followed by a Q&A session with speakers.Wales 21 Jan 2022 Training, Reports & Research, Strategy & Planning Video -
A peer-based needle exchange service in London
Funded by Hackney Council as part of the ADDER (addiction, diversion, disruption, enforcement and recovery) Accelerator project, the London Joint Working Group on Substance Use and Hepatitis C (LJWG) have a released a report exploring the feasibility, acceptability, and practical considerations of developing a peer-based needle exchange service. It draws on focus groups with people who use needle exchange services and peer support workers, interviews with experts from services and commissioning bodies, and international evidence.Greater London 18 Jan 2022 Reports & Research PDF -
National Hepatitis C ODN Stakeholder Webinar Series 2021 summary report
The HCV Action National Hepatitis C ODN Stakeholder Webinar series took place over the course of November 2021, bringing together ODN representatives and a range of partners and colleagues working on the hepatitis C elimination programme for the third annual event. In addition to a half-day series of presentations, ‘breakout’ webinars were held on specific areas of hepatitis C care: hepatitis C in the criminal justice system; hepatitis C in community pharmacies; and hepatitis C reinfections & harm prevention. This resource offers a detailed summary of each webinar and its presentations.UK 22 Dec 2021 Reports & Research, Strategy & Planning PDF